Navigation Links
PRS And EmSense Partner To Integrate Bio-Sensory Measures In Packaging Research Studies
Date:7/21/2009

CHICAGO, July 21 /PRNewswire/ -- Last week at the IIR Shopper Insights Conference, Perception Research Services International (PRS) and EmSense Corporation announced their partnership to include bio-sensory measures within quantitative packaging research studies. The companies presented findings from a recent joint study, that used PRS Eye-Tracking and EmSense's EmGear(TM) EEG unit to link package viewing patterns with measures of cognition and emotion - and to identify the specific design elements driving the recent failure of Tropicana's new packaging. These new insights, which help uncover the linkage between visibility, cognition, emotion and purchase, will now be available within PRS On-Shelf Packaging Assessment studies.

Scott Young, President of PRS, commented, "Our focus is on helping companies 'win at retail' through effective packaging -- and we've used bio-sensory measures (such as PRS Eye-Tracking) for many years to understand shopper behavior at the shelf. Linking package viewing patterns to additional bio-sensory measures of emotion and cognition through our partnership with EmSense will help us take this to a new level."

"We aim to give manufacturers an in-depth understanding of consumers' visceral reactions toward packaging by linking EmSense technology with PRS' expertise," shared Keith Winter, CEO and President of EmSense. "We are excited to work with PRS, offering the most advanced neuromarketing solution for packaging research available."

To learn more about this new bio-sensory packaging research offering, contact Jeni Lee Chapman at jchapman@prsresearch.com.

About Perception Research Services International

Established in 1972, PRS' mis
'/>"/>

SOURCE Perception Research Services International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
2. Another JDRF partner moves research forward with collaboration agreement for diabetes treatment
3. Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
4. Partnership to accelerate Trudeau Institute discoveries to patient care
5. Supply Chain Council Partners With APICS The Association for Operations Management
6. BIO-key(R) Enters Strategic Partnership With Nlets
7. BIO-key(R) Enters Strategic Partnership With Nlets
8. Supply Chain Council Partners With APICS The Association for Operations Management
9. Regional partnership to develop algal biofuels gets backing of San Diego leaders
10. Springer partners with the American Society for Biochemistry and Molecular Biology
11. CFI awards $854,098 to University of Montreal and partners

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire/ -- DigitalPersona, Inc., a leader in finge...y announced an agreement with IBM to deploy a new ...technology on IBM SurePOS 500 retail systems. The ...s point-of-sale applications to more easily and qu... can be linked to the individuals who perform them...
(Date:12/2/2009)...a and another from Yale University have shown that...f Acanthodactylus beershebensis , a lizard specie...g to the study, these reptiles move less and catch...pressure from predators. , Many theoretical mode...had been very few experimental trials and none in ...
(Date:12/1/2009)...unce the publication of results from its Phase II ...rability of its novel, intranasal drug/device prod...sitis with nasal polyps in Rhinology , the offici...logic Societies. , Chronic rhinosinusitis with ...cantly reduce a patient,s quality of life, causing...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Lizards change their diet to avoid predators 2New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 1Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 2Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 3Transdel Pharmaceuticals Enters Into License Agreement with JH Direct LLC for Cosmeceutical Product 48420 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 1Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 2Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 3Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 5Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 6Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 7Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 8Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 9AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 1AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 2AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 3AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 4AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia 12555 5
...ife boils down to two basic missions: eat, and avo...a tadpole eats, the faster it grows big enough to ...eing active, which ups the odds of becoming someon...ey adjust their activity levels in response to pre...ichigan graduate student shows that internal facto...
...cal Center researchers have discovered how the bra...he nose. , In studies in mice, the researchers fou...-- the first stop for information from the nose --...objects, such as the fragrance of a blooming rose....e host of chemical compounds that comprise a rose,...
...ble doctors to predict which smokers using the nic...unt of cravings and have the highest probability o... results of a study in the June issus of the Journ...The blood test, which is a measure of the rate at ...erformed non-invasively using saliva or urine samp...
Other Biology News:Time of day tempers tadpoles' response to predators 2Researchers show how brain decodes complex smells 2Blood test predicts success of quitting smoking using the nicotine patch 2
(Date:12/2/2009)...., Dec. 2 TechConnect World, an ev...velopment and product integration in cleantech, na...1th deadline for technology abstracts and business...nnect World, in association with the Nano Science ...hnology and Sustainable Industries Organization (C...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutic... ), a leading pharmaceutical company,specializing ...f branded,generic and proprietary pharmaceuticals ...ve been included in China,s National Drug Reimburs...inistry of Human Resources and Social,Security on ...
(Date:12/2/2009)...2 According to the National Instit...ns diagnosed with diabetes already have some stage...amage to the retina caused by leaky blood vessels,...etes and is one of the most feared diabetic compli...s who,ve had diabetes for 10 years or more will ex...
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Industrial Enzymes - A Global Mar...64431/Industrial-Enzymes---A-Global-Market-Report....oly with few strong players and a host of small su...ompetition and commoditization characterize the in...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
... Institute of Aeronautics and Astronautics has pub...e , that compiles for the first time the emerging ... drives, warp drives, gravity control, and faster-...ionize spaceflight and enable human voyages to oth...sound like science fiction, authors Marc Millis an...
...armaceuticals, Inc. (Nasdaq: ALXA ) announced to...will present during the 11th Annual BIO CEO & ...at 2:45 p.m. ET. The presentation,will be webcast... To access the presentation via the Web, pleas...com or at, http://www.corporate-ir.net/ireye/conf...
...alth,Inc. (Nasdaq: GHDX ) today reported financi...arter and year ended December 31, 2008. , Tota... to $31.2 million,compared with $19.3 million in t...he Oncotype DX(R) breast cancer assay was $30.9 mi...f 60 percent, compared with $19.3 million in the,f...
Other Biology Technology:New book from AIAA explores space drives, warp drives 2Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference 2Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 2Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 4Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 5Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 6Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 7Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 8Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 9
...olabeled Ligands\n\nReceptor-related research has ... new radiolabeled ligands selected to keep pace wi...e of products and services for receptor research a...-art radioligands. If you do not find exactly what...
Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
iTaq DNA Polymerase, 5,000 U from Bio-Rad
Rabbit Anti-hnRNP-U Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: